Alvotech Files for $200M At-the-Market Offering
Ticker: ALVOW · Form: 6-K · Filed: Jun 14, 2024 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Jun 14, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.01, $75 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: at-the-market offering, equity issuance, capital raise
TL;DR
Alvotech just filed to sell up to $200M in stock on the open market.
AI Summary
On June 14, 2024, Alvotech entered into an Open Market Sale Agreement with an unspecified sales agent. This agreement allows Alvotech to issue and sell up to $200 million of its common shares from time to time.
Why It Matters
This filing indicates Alvotech is seeking to raise capital through the sale of its stock, which could be used for general corporate purposes or strategic initiatives.
Risk Assessment
Risk Level: medium — The company is seeking to raise a significant amount of capital, which could dilute existing shareholders or signal a need for funds.
Key Numbers
- $200.0M — At-the-Market Offering Size (Maximum amount of common shares Alvotech can sell)
Key Players & Entities
- Alvotech (company) — Registrant
- June 14, 2024 (date) — Date of Sales Agreement
- $200 million (dollar_amount) — Maximum offering amount
FAQ
What is the purpose of the Open Market Sale Agreement?
The agreement allows Alvotech to issue and sell up to $200 million of its common shares from time to time, likely for general corporate purposes.
Who is the sales agent for the Open Market Sale Agreement?
The filing does not specify the name of the sales agent involved in the Open Market Sale Agreement.
What is the maximum amount Alvotech can raise through this agreement?
Alvotech can raise up to $200 million through the sale of its common shares under this agreement.
When was the Sales Agreement entered into?
The Sales Agreement was entered into on June 14, 2024.
What type of securities will be sold under the agreement?
The agreement pertains to the sale of Alvotech's common shares.
Filing Stats: 1,553 words · 6 min read · ~5 pages · Grade level 12.6 · Accepted 2024-06-14 16:36:17
Key Financial Figures
- $0.01 — ll the Company’s ordinary shares, $0.01 nominal value per share (the “Ord
- $75 million — ng an aggregate offering price of up to $75 million from time to time, in at-the-market off
Filing Documents
- c109147_6k.htm (6-K) — 25KB
- c109147_ex1-1.htm (EX-1.1) — 245KB
- c109147_ex5-1.htm (EX-5.1) — 47KB
- c109147_ex99-1.htm (EX-99.1) — 106KB
- 0000930413-24-001877.txt ( ) — 425KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ALVOTECH Date: June 14, 2024 By: /s/ Tanya Zharov Name: Tanya Zharov Title: General Counsel